ASHINGTON  — As 200 health care data wonks packed into a room just a block from the White House to consider the question of how to use “real world” data to do clinical research, they struggled with the fact that the health care system has been generating reams of data unfit for that specific purpose.

“What we have is an [electronic health record] system that is not primarily built for research, and yet we need to see if we can use it for research,” Rich Moscicki, the Food and Drug Administration’s deputy center director for science operations at the Center for Drug Evaluation and Research, told STAT. In October Moscicki will join Pharmaceutical Research and Manufacturers of America as the trade group’s chief medical officer and executive vice president.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.